Transitional cell carcinoma pathophysiology: Difference between revisions
Line 118: | Line 118: | ||
===Grading=== | ===Grading=== | ||
According to the WHO grading criteria, there are | According to the WHO grading criteria, there are two grades of transitional cell carcinoma based on the degree of cellular differentiation: | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 800px" | {| style="border: 0px; font-size: 90%; margin: 3px; width: 800px" | ||
|valign=top| | |valign=top| | ||
Line 127: | Line 126: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; align=left" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; align=left" | | ||
Low grade | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=left | | | style="padding: 5px 5px; background: #F5F5F5;" align=left | | ||
*Tumors with the least degree of cellular anaplasia compatible with a diagnosis of malignancy | *Tumors with the least degree of cellular anaplasia compatible with a diagnosis of malignancy | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; align=left" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; align=left" | | ||
High grade | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=left | | | style="padding: 5px 5px; background: #F5F5F5;" align=left | | ||
*Tumors with the most severe degrees of cellular anaplasia | *Tumors with the most severe degrees of cellular anaplasia |
Revision as of 15:21, 12 February 2016
Transitional cell carcinoma Microchapters |
Differentiating Transitional cell carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Transitional cell carcinoma pathophysiology On the Web |
American Roentgen Ray Society Images of Transitional cell carcinoma pathophysiology |
Directions to Hospitals Treating Transitional cell carcinoma |
Risk calculators and risk factors for Transitional cell carcinoma pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Pathophysiology
Gross Pathology
The following table illustrates the findings on gross pathology for the subtypes of transitional cell carcinoma:[1][2][3]
Type | Description |
---|---|
Non-invasive urothelial carcinoma |
|
Invasive urothelial carcinoma |
|
Microscopic Pathology
Non-invasive urothelial carcinoma
- Non-invasive urothelial carcinomas are only in the lining of the renal pelvis or ureter and have not grown deeper into the wall of the renal pelvis or ureter.
Invasive urothelial carcinoma
- Invasive urothelial carcinomas grow from the lining of the renal pelvis or ureter into the deeper layers of the renal pelvis or ureter wall, such as lamina propria and muscularis.
- Urothelial carcinomas with mixed epithelial features are invasive tumors that have different types of cells mixed with the cancer cells.
- They occur less often than typical invasive urothelial carcinomas and are generally considered to be more aggressive.
- The following table illustrates the findings on microscopic analysis for the subtypes of invasive transitional cell carcinoma:
Subtype | Description |
---|---|
Urothelial carcinomas with squamous differentiation |
|
Urothelial carcinomas with glandular differentiation |
|
Micropapillary urothelial carcinomas |
|
Sarcomatoid urothelial carcinomas |
|
Nested variant of urothelial carcinomas |
|
Microcystic urothelial carcinomas |
|
Lymphoepithelioma-like urothelial carcinomas |
|
Plasmacytoid and lymphoma-like urothelial carcinomas |
|
Giant cell urothelial carcinomas |
|
Clear cell urothelial carcinomas |
|
Lipid cell variant of urothelial carcinomas |
|
Undifferentiated variant of urothelial carcinomas |
|
Urothelial carcinomas with trophoblastic differentiation |
|
Grading
According to the WHO grading criteria, there are two grades of transitional cell carcinoma based on the degree of cellular differentiation:
Grade | Description |
---|---|
Low grade |
|
High grade |
|
References
- ↑ Cheng L, Cheville JC, Neumann RM, Bostwick DG (2000). "Flat intraepithelial lesions of the urinary bladder". Cancer. 88 (3): 625–31. PMID 10649257.
- ↑ Cheng L, Cheville JC, Neumann RM, Bostwick DG (1999). "Natural history of urothelial dysplasia of the bladder". Am J Surg Pathol. 23 (4): 443–7. PMID 10199474.
- ↑ Pons F, Orsola A, Morote J, Bellmunt J (2011). "Variant forms of bladder cancer: basic considerations on treatment approaches". Curr Oncol Rep. 13 (3): 216–21. doi:10.1007/s11912-011-0161-4. PMID 21360040.